Targeting iNOS to increase efficacy of immunotherapies
Inducible NO synthase (iNOS/NOS2) protein expression is a well-studied predictor of poor outcome in multiple cancers, and it has also been associated with inflammatory and immunosuppressive processes in the tumor microenvironment. Immunotherapies are becoming increasingly key components in cancer tr...
Saved in:
Main Authors: | Suhendan Ekmekcioglu (Author), Elizabeth A. Grimm (Author), Jason Roszik (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic effects of iNOS inhibition against vitiligo in an animal model
by: Hamid Mansourpour, et al.
Published: (2019) -
Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway
by: Yazmín K. Márquez-Flores, et al.
Published: (2024) -
Crambescin C1 Acts as A Possible Substrate of iNOS and eNOS Increasing Nitric Oxide Production and Inducing In Vivo Hypotensive Effect
by: Juan A. Rubiolo, et al.
Published: (2021) -
Role of iNOS and eNOS expression in a group of Egyptian diabetic and nondiabetic nephropathy patients
by: Mayssa I. Aly, et al.
Published: (2013) -
The association between chronic pancreatitis and the iNOS-2087A>G polymorphism
by: Pădureanu Vlad, et al.
Published: (2017)